Morgan Adam
SEC insider (Form 3/4/5 filer). CIK 0001964335. Director at HERON THERAPEUTICS, INC. /DE/ (HRTX) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Jan 30, 2026. Located in CARY, NC.
Companies Morgan Adam has filed insider reports for
- HERON THERAPEUTICS, INC. /DE/ (HRTX): Director
- ALIMERA SCIENCES INC (ALIM): Director, 10% Owner
Morgan Adam
CIK: 0001964335
Transaction Breakdown
Open Market Buys (P)1 (16.7%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jan 30, 2026HRTX
HERON THERAPEUTICS, INC. /DE/
AwardDirect54K shares- - Aug 8, 2025HRTX
HERON THERAPEUTICS, INC. /DE/
PurchaseIndirect1.8M shares at avg. $1.50$2.6M - Jan 31, 2025HRTX
HERON THERAPEUTICS, INC. /DE/
AwardDirect18K shares- - Jan 30, 2025HRTX
HERON THERAPEUTICS, INC. /DE/
AwardDirect18K shares- - Sep 16, 2024ALIM
ALIMERA SCIENCES INC
DispositionIndirect9.4M shares- - Sep 16, 2024ALIM
ALIMERA SCIENCES INC
DispositionIndirect4.2M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 30, 2026 |  HRTX HERON THERAPEUTICS, INC. /DE/ | Award | 53,960 | - | $0 | Direct |
| Aug 8, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | Purchase | 1,766,546 | $1.50 | $2,649,819 | Indirect |
| Jan 31, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | Award | 17,950 | - | - | Direct |
| Jan 30, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | Award | 17,950 | - | - | Direct |
| Sep 16, 2024 |  ALIM ALIMERA SCIENCES INC | Disposition | 9,429,808 | - | $0 | Indirect |
| Sep 16, 2024 | ALIM ALIMERA SCIENCES INC | Disposition | 4,178,725 | - | $0 | Indirect |
1-6 of 6 transactions